1.
Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients...
by Faergeman, Ole, MD, DMSc
The American journal of cardiology, 2009, Vol.104 (4), p.459-463
2.
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
by Strandberg, Timo E
The Lancet (British edition), 2004-08-28, Vol.364 (9436), p.771-777
3.
Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering
by Pedersen, Terje R
The American journal of cardiology, 2000, Vol.86 (3), p.257-262
4.
The atherosclerosis epidemic: Methodology, nosology, and clinical practice
by Faergeman, Ole
The American journal of cardiology, 2001, Vol.88 (2), p.4-7
5.
Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study
by Pedersen, Terje R
The American journal of cardiology, 2004, Vol.94 (6), p.720-724
6.
How can we identify low- and high-risk patients among unselected patients with possible acute coronary syndrome?
by Nielsen, Kirsten Melgaard, MD, PhD
The American journal of emergency medicine, 2007, Vol.25 (1), p.23-31
7.
A Unique Pattern of apo(a) Polymorphism in an Isolated East Greenlandic Inuit (Eskimo) Population
by KLAUSEN, I. C
European journal of epidemiology, 1995-10-01, Vol.11 (5), p.563-568
8.
Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons
by Nielsen, K M
Journal of epidemiology and community health (1979), 2006-08, Vol.60 (8), p.721-728
9.
Differences in apolipoprotein(a) polymorphism in West Greenland Eskimos and Caucasian Danes
by KLAUSEN, C
Human genetics, 1992, Vol.89 (4), p.384-388
10.
Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol
by Vigholt-Sørensen, E
British Heart Journal, 1990-09, Vol.64 (3), p.186-189
11.
A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a)
by KLAUSEN, I. C
Human genetics, 1993, Vol.91 (2), p.193-195
12.
Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension
by Ott, Peter
The American journal of cardiology, 1987, Vol.59 (14), p.G73-G77
13.
Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study
by Sorensen, E V
Cardiovascular drugs and therapy, 1989-04, Vol.3 (2), p.203-209
